Top Markets
#1 MowCat MowCat +48.88%
#2 Bermuda Shorts Bermuda Shorts +25.32%
#3 Velvet Velvet +25.02%
#4 Biconomy Biconomy +24.70%
#5 Audiera Audiera +24.55%
#6 aPriori aPriori +21.94%
#7 Quack AI Quack AI +20.17%
#8 Derive Derive +18.67%
#9 SkyAI SkyAI +13.30%
#10 Geodnet Geodnet +11.28%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

CLGN
Rank in Stocks #35204
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine... CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen. Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores. The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.
Share Price
$0.3299
Last synced: 2026-08-14
Market Cap
$4.28M
Change (1 day)
3.55%
Change (1 year)
-87.06%
Country
IL
Trade CollPlant Biotechnologies Ltd. (CLGN)

Category

Healthcare
Number of shares outstanding for CollPlant Biotechnologies Ltd. (CLGN)
Number of shares outstanding as of August 2026: 0
According to CollPlant Biotechnologies Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for CollPlant Biotechnologies Ltd. (CLGN) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE